MELISSA MCCARTER: Open Payments
NPI 1356305106 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,975 in 148 payments from 19 companies in 2025. Trend: 2023 $2,963 · 2024 $2,313 · 2025 $2,975
Food & beverage: $2,975
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 24 | $528 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $482 |
| Vanda Pharmaceuticals Inc. | 8 | $258 |
| Teva Pharmaceuticals USA, Inc. | 12 | $244 |
| Axsome Therapeutics, Inc. | 13 | $216 |
| E.R. Squibb & Sons, L.L.C. | 12 | $188 |
| Lundbeck LLC | 9 | $166 |
| Alkermes, Inc. | 7 | $163 |
| Janssen Pharmaceuticals, Inc | 11 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $136 |
Products named: INGREZZA, CAPLYTA, REXULTI, AUSTEDO XR, HETLIOZ, COBENFY, Auvelity, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
